Shares of Hikma Pharmaceuticals PLC (LON:HIK – Get Free Report) crossed above its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of GBX 1,928.90 ($23.47) and traded as high as GBX 2,102 ($25.57). Hikma Pharmaceuticals shares last traded at GBX 2,091.92 ($25.45), with a volume of 345,375 shares traded.
Hikma Pharmaceuticals Stock Performance
The company has a market cap of £4.64 billion, a P/E ratio of 3,218.34, a PEG ratio of 2.38 and a beta of 0.41. The company has a quick ratio of 1.27, a current ratio of 1.66 and a debt-to-equity ratio of 55.48. The company has a 50 day moving average price of GBX 1,949.17 and a 200-day moving average price of GBX 1,928.90.
About Hikma Pharmaceuticals
At Hikma we help put better health within reach, every day. By creating high-quality medicines and making them accessible to the people who need them, we help to shape a healthier world that enriches all our communities. We help deliver this by living our culture, delivering our strategy, and acting responsibly.
Featured Stories
- Five stocks we like better than Hikma Pharmaceuticals
- What is Short Interest? How to Use It
- AI Demand Sparks Opportunities for These 3 Nuclear Energy Leaders
- What is the NASDAQ Stock Exchange?
- TSMC: Long-Term Outlook Still Strong as Geopolitical Risk Rises
- Basic Materials Stocks Investing
- Uber’s NVIDIA Deal and Buybacks Signal Major Upside
Receive News & Ratings for Hikma Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hikma Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
